Evaluation of Different Etiologies of Obscure Ascites

Sponsor
Assiut University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03205748
Collaborator
(none)
50
1
15
3.3

Study Details

Study Description

Brief Summary

Ascites refers to fluid that accumulates within the peritoneal cavity. Although ascites is most commonly observed in patients with cirrhosis and resulting portal hypertension (approximately 85% of cases), 7% to 10% of patients with ascites develop secondary to a malignancy

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of Different Etiologies of Obscure Ascites: Clinical, Laboratory, and Laparoscopic Study.
    Actual Study Start Date :
    Aug 1, 2017
    Anticipated Primary Completion Date :
    Aug 1, 2018
    Anticipated Study Completion Date :
    Nov 1, 2018

    Outcome Measures

    Primary Outcome Measures

    1. The percentage of patients with malignant ascites [1 month]

      according to laboratory and clinical criteria

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with ascites

    • serum ascites albumin gradient >1.1.

    Exclusion Criteria:
    • ascitic fluid serum ascites albumin gradient <1.1.

    • Haemorrgaic ascites;

    • chylous ascites

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Assiut Faculty of Medicine Assiut Egypt

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ahmed Mohamed Abbas, Principal investigator, Assiut University
    ClinicalTrials.gov Identifier:
    NCT03205748
    Other Study ID Numbers:
    • OA
    First Posted:
    Jul 2, 2017
    Last Update Posted:
    Nov 29, 2017
    Last Verified:
    Nov 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 29, 2017